Speaker illustration

Ms Saranda Nimani

University of Bern, Bern (Switzerland)

In vivo KCNH2-suppression-replacement gene therapy attenuates the pathogenic phenotype in transgenic rabbits with short QT syndrome type 1

Event: EHRA 2024

Topic: Ion Channels, Electrophysiology

Session: Young Investigator Award Basic and Translational Science

Thumbnail

Differences in extent of mechano-induced QT-changes in SQTS, WT and LQTS rabbit models

Event: ESC Congress 2021 - The Digital Experience

Topic: Ion Channels, Electrophysiology

Session: Basic science e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb